2021 ILiAD Biotechnologies closes a $23.9 million Convertible Note Offering
June 2020 Seneca Therapeutics closed a $3 million Series A round.
2020 GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures
Read the full press release
2019-2020 ILiAD Biotechnologies Secures Up to $20 million of Financing and Phase 2a BPZE1 Pertussis Vaccine Trial Initiates at Vanderbilt University Medical Center
Read the full press release
2019-2020 Seneca Therapeutics closed on a $780,000 KISS financing
June 2019 ILIAD Biotechnologies BPZE1 vaccine mentioned in CNN Report: Whooping cough vaccine becomes less effective over time, study says
2019 Seneca Therapeutics closed on a $500,000 KISS financing
2018 GPB Scientific closes $2.5 million convertible note round
Fall 2017 FORGE Life Sciences raises $500,000 from angel investors
Summer 2017 Illuminare Biotechnologies closed a $2.3M Series A round
July 2017 ILiAD Biotechnologies BPZE1 Pertussis Vaccine Reaches Key Milestones Including Positive Phase 1b Clinical Study Data
Read the full press release...
2017-2018 RenalSense raises $3.5 million from angel investors
2017 GPB Scientific raises $1.0 million from angel investors
2016-2017 ILiAD Biotechnologies raises $2.6 million from angel investors
Spring 2016 GPB Scientific raises $1.0 million from angel investors.
Spring 2016 ILiAD Biotechnologies raises $1.0 million from angel investors.
Fall 2015 GPB Scientific closes $1.6 million Series A round.
Fall 2015 RenalSense closes $3.6 million Series A round.
Fall 2015 ILiAD Biotechnologies closes $3.7 million financing round.
March 2014 CytoSorbents Corporation Announces $10.2 Million Registered Direct Offering.
Click here to read the full press release
March 2014 GPB Scientific raises $700,000 from angel investors.
November 2013 Callidus Biopharma acquired by Amicus Therapeutics (NASDAQ-FOLD) for $15 million upfront payment with potential milestone payments totaling $115 million. Click here to read the full press release
November 2013 Hygeia Therapeutics acquired by Stratus Media Group (OTCBB-SMDI).
Click here to read the full press release
October 2013 CytoSorbents raises $200,000 from angel investors.
May 2013 Callidus Biopharma announces $4.6 million Series A financing
Read the full press release
March 2013 Callidus Biopharma receives $3.0 million from strategic investors
December 2012 Callidus Biopharma successfully generates in vivo proof of concept data
January 2012 Callidus Biopharma receives $1.6 million from Angel and strategic investors
October 2011 Core Essence Orthopaedics launches PONTiS™, a novel endotendonous implant for minimally invasive repair of severed tendons
September 2011 Lerner Medical Devices closes on a $1M Angel financing
July 2011 Advanced BioHealing Acquired by Shire Pharmaceuticals for $750M
June 2011 WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise by China's Ministry of Commerce
March 2011 Core Essence Orthopaedics receives an $11.3M Series B round led by Baird Venture Partners
March 2011 WuXi PharmaTech announces collaboration with BMS for a new analytical and stability testing facility
October 2010 Core Essence Orthopaedics closes on a $2.9M Convertible Debt from Angel Investors
May 2011 QuantumBio and Chemical Computing Group announce release of DivCon Discovery Suite for MOE
March 2010 Hygeia Therapeutics closes on a $2.0M round from Angel Investors
November 2009 Lerner Medical Devices receives 510(k) clearance for Levia® Targeted Phototherapy for Self-Treatment at home
October 2009 WuXi PharmaTech receives 2009 Schering-Plough Excellence Award
December 2007 Lerner Medical Devices closes on a $3.3M Angel Round to develop Levia® device
2007 WuXi PharmaTech publicily listed in NYSE. Read More